Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / SHS NEW
-
Total 13F shares
-
1,430,658
-
Share change
-
-88,636
-
Total reported value
-
$9,140,510
-
Put/Call ratio
-
94%
-
Price per share
-
$6.39
-
Number of holders
-
15
-
Value change
-
-$561,195
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q4 2023
As of 31 Dec 2023,
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,430,658 shares.
The largest 10 holders included
PINNACLE ASSOCIATES LTD, Roumell Asset Management, LLC, VILLERE ST DENIS J & CO LLC, BROWN ADVISORY INC, BENJAMIN F. EDWARDS & COMPANY, INC., Zurcher Kantonalbank (Zurich Cantonalbank), BANK OF AMERICA CORP /DE/, CITADEL ADVISORS LLC, PNC FINANCIAL SERVICES GROUP, INC., and FNY Investment Advisers, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.